Physician profile
Bradley Bloom
NPI 1780902585
$17,488.21
in general payments reported to CMS, 2019-2025
13 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $15K · 2021: $113 · 2022: $454 · 2023: $221 · 2024: $807 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,270.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15,615.29 | 2019-2022 | |
| Abbvie INC. | $631.90 | 2023-2025 | Botox |
| Revance Therapeutics, INC. | $523.70 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $446.09 | 2019-2024 | |
| Merz North America, INC. | $52.91 | 2021 | |
| Lilly USA, LLC | $38.75 | 2023-2024 | Olumiant |
| Pfizer INC. | $36.43 | 2021-2022 | |
| Journey Medical Corporation | $35.80 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $28.60 | 2022 | |
| Endo Pharmaceuticals INC. | $23.44 | 2019 | |
| Incyte Corporation | $22.24 | 2022 | |
| Mayne Pharma Commercial LLC | $21.08 | 2023 | |
| Mission Pharmacal Company | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.